Cargando...
Modeling Cost-Effectiveness of a Biomarker-Based Approach to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
OBJECTIVES: To model the cost-effectiveness (CE) of a biomarker-based approach to select patients for neoadjuvant chemotherapy (NAC) prior to radical cystectomy (RC) in muscle-invasive bladder cancer (MIBC). MATERIALS AND METHODS: We obtained most recently clinical studies on locally-advanced bladde...
Guardado en:
| Publicado en: | BJU Int |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6126977/ https://ncbi.nlm.nih.gov/pubmed/29603871 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bju.14220 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|